Eczema Drug Restores Nails in Boy With Rare 19-Nail Dystrophy, Case Report Shows
A case report describes a seven-year-old boy with dystrophy of 19 nails and no eczema whose nails nearly normalized after ...
A case report describes a seven-year-old boy with dystrophy of 19 nails and no eczema whose nails nearly normalized after ...
Monoclonal antibody therapy, led by dupilumab, is transforming the treatment of eosinophilic esophagitis in children after decades of limited options.
A 48-week case report describes how the IL-4/IL-13 blocker dupilumab improved atopic dermatitis, asthma and eosinophilic esophagitis in a seven-year-old ...
The distinction between T2-high and T2-low asthma represents one of the most consequential shifts in modern respiratory medicine. Type 2 ...
A large real-world study of Medicare beneficiaries found mepolizumab matched dupilumab for preventing asthma hospitalizations and significantly reduced exacerbation rates, ...
A retrospective study of 26 Japanese patients finds that roughly one in five cases of prurigo chronica multiformis tests positive ...
A new systematic review of 172 patients finds that dupilumab, omalizumab, and JAK inhibitors can meaningfully control severe atopic disease ...
A genetically confirmed case of Costello syndrome shows that the biologic drug dupilumab resolved severe, treatment-refractory eczema within one month, ...
A non-invasive nasal secretion biomarker, secretory IL-17A, predicts which patients with severe chronic rhinosinusitis with nasal polyps will regain their ...
A cross-sectional analysis using the NIH All of Us Research Program compares the clinical characteristics and lifestyle factors of Black ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine